CN112375750A - Glycosyltransferase mutant and method for catalytically synthesizing rebaudioside A by using same - Google Patents

Glycosyltransferase mutant and method for catalytically synthesizing rebaudioside A by using same Download PDF

Info

Publication number
CN112375750A
CN112375750A CN202011388873.6A CN202011388873A CN112375750A CN 112375750 A CN112375750 A CN 112375750A CN 202011388873 A CN202011388873 A CN 202011388873A CN 112375750 A CN112375750 A CN 112375750A
Authority
CN
China
Prior art keywords
mutant
leu
glycosyltransferase
glu
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202011388873.6A
Other languages
Chinese (zh)
Other versions
CN112375750B (en
Inventor
李艳
贾红华
余杰
孙萍
齐雪莲
严明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Tech University
Original Assignee
Nanjing Tech University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Tech University filed Critical Nanjing Tech University
Priority to CN202011388873.6A priority Critical patent/CN112375750B/en
Publication of CN112375750A publication Critical patent/CN112375750A/en
Application granted granted Critical
Publication of CN112375750B publication Critical patent/CN112375750B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1051Hexosyltransferases (2.4.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/18Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/56Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/584Recycling of catalysts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a glycosyltransferase mutant and a method for catalytically synthesizing rebaudioside-A thereof, wherein the amino acid sequence of the primary glycosyltransferase is as follows: 1, the experiment starts from a surface residue Q, N, T of UGT76G1, and combines the analysis results of solvent accessible surface area, B-factor and other data, single-point or multi-point iterative mutation in Asn196, Asn78, Asn400, Asn69, Gln72, Gln198, Gln178, Gln160, Thr319 and Thr 81 is screened out on the basis of the obtained prediction, and finally a better UGT-SuSy system of a mutant strain 76G1_ Q72E-N196D-T319E is screened out, so that high-efficiency catalytic synthesis of rebaudioside A is realized. And (3) connecting the glycosyltransferase UGT76G1 or mutant genes thereof with a sucrose synthase gene to obtain a recombinant plasmid, and constructing a recombinant strain with double-enzyme co-expression. By constructing a double-enzyme system, the regeneration of the UDPG in vivo is realized, the problem of the source of an expensive glycosyl donor is effectively solved, the cost is reduced, and the application of the biotechnology industry is promoted. The mutant is simple to prepare, realizes the catalytic synthesis of rebaudioside A in a short time and high efficiency, is green, environment-friendly and pollution-free in a biological enzyme catalysis method, and is more suitable for the current green industrial processing production.

Description

Glycosyltransferase mutant and method for catalytically synthesizing rebaudioside A by using same
Technical Field
The invention belongs to the technical field of bioengineering, and particularly relates to a glycosyltransferase mutant and a method for catalytically synthesizing rebaudioside A by the glycosyltransferase mutant.
Background
Steviol glycosides are tetracyclic diterpenoids, readily soluble in water and dioxane, soluble in part of the organic reagent. Good heat resistance and is not easy to decompose in the presence of light. The basic skeleton of stevioside is tetracyclic diterpene glycoside, and the variety of stevioside compounds is formed due to the variety of glycosyl groups, the addition positions (C13 and C19) and the number of the glycosyl groups. Mainly comprises steviol, stevioside, rebaudioside A, B, C, D, E, M and the like. Among them, Stevioside (St glycoside) is the most abundant in stevia rebaudiana and Rebaudioside A (RA glycoside) is the second, and accounts for about 3.8% of the dry weight of the leaves.
Rebaudioside a (RA glycoside) is a natural sweetener derived from stevia rebaudiana, has high sweetness and low calorie, and can well meet the sweet taste requirement of modern people on healthy diet. At present, RA glycoside is mainly obtained by extraction method, and can also be obtained by catalyzing Stevioside (St glycoside) by glycosyl transferase UGT76G1 from stevia rebaudiana through enzymatic conversion. Stevia-derived glycosyltransferase UGT76G1 (UDP-glycosyltransferase 76G 1) is a "Leloir" type glycosyltransferase, belongs to the GT1 family, and is usually synthesized into glycoside compounds by using UDPG as a glycosyl donor. UGT76G1 was first reported by HUMPHREY T V and RICHMAN A et al. Glycosyltransferase UGT76G1 is extracted from stevia rebaudiana Bertoni originally, and then can be obtained in large quantities by heterologous expression of escherichia coli or saccharomyces cerevisiae and the like, and is used for catalyzing St glycoside to synthesize RA glycoside in one step. The higher cost of the pre-glycosyl donor UDPG material limits the large-scale application of UGT76G 1. With the continuous improvement of the production method of UDPG, it can be synthesized in large quantities by enzyme method such as SuSy. Researchers use a SuSy-UGT cascade reaction system on the basis, and provide glycosyl donors for UGT76G1 by using SuSy, so that cyclic utilization of UDPG is realized, and application cost is greatly reduced. In the UGT76G1-SuSy cascade system, SuSy provides the necessary glycosyl donor for glycosylation reaction, and when UDPG regeneration speed is not limited (for example, by increasing sucrose concentration), the key to high and low RA glycoside synthesis efficiency is UGT76G 1. The soluble expression quantity of stevia-derived UGT76G1 in escherichia coli is very low, and the high-efficiency application of glycosyltransferase is limited.
Disclosure of Invention
The invention aims to provide a glycosyltransferase mutant and a method for catalytically synthesizing rebaudioside A by using the glycosyltransferase mutant; the mutant gene is utilized to realize glycosylation modification of stevioside, rebaudioside A is prepared by high-efficiency catalysis, and a certain reference is provided for industrial production.
In order to achieve the purpose, the technical scheme adopted by the application is as follows:
a glycosyltransferase mutant suitable for rebaudioside A synthesis, the glycosyltransferase amino acid sequence is shown in SEQ ID NO. 1, and the glycosyltransferase mutant is obtained by single-point or multi-point iterative mutation of Asn196, Asn78, Asn400, Asn69, Gln72, Gln198, Gln178, Gln160, Thr319 and Thr 81 through at least one of the following mutations:
N196D is the mutation of amino acid 196 in the sequence of SEQ ID NO. 1 from aspartyl (N) to aspartic acid (D);
N78D is the mutation of 78 th amino acid from aspartyl (N) to aspartic acid (D) in the sequence of SEQ ID NO. 1;
N400D is SEQ ID NO. 1, wherein the 400 th amino acid of the sequence is mutated from aspartyl (N) to aspartic acid (D);
N69D is SEQ ID NO. 1, wherein the 69 th amino acid is mutated from aspartyl (N) to aspartic acid (D);
Q72E is the 72 th amino acid in the SEQ ID NO. 1 sequence, and glutamine (Q) is mutated into glutamic acid (E);
Q198E is the mutation of amino acid 198 in the sequence of SEQ ID NO. 1 from glutamine (Q) to glutamic acid (E);
Q178E is the amino acid 478 of the SEQ ID NO:1 sequence, and glutamine (Q) is mutated into glutamic acid (E);
Q160E is the amino acid at position 160 in the sequence of SEQ ID NO. 1, which is mutated from glutamine (Q) to glutamic acid (E);
T319E is SEQ ID NO. 1 in which amino acid 319 is mutated from threonine (T) to glutamic acid (E);
T81E is SEQ ID NO. 1, wherein the 81 st amino acid is mutated from threonine (T) to glutamic acid (E);
Q72E-N196D is the amino acid 72 of the SEQ ID NO. 1 sequence mutated from glutamine (Q) to glutamic acid (E) and from aspartyl (N) to aspartic acid (D);
N196D-T319E is SEQ ID NO 1 sequence with aspartyl (N) at amino acid position 196 mutated to aspartic acid (D) and threonine (T) at amino acid position 319 mutated to glutamic acid (E);
Q72E-N196D-T319E is the mutation of amino acid 72 from glutamine (Q) to glutamic acid (E) and amino acid 196 from aspartyl (N) to aspartic acid (D) and amino acid 319 from threonine (T) to glutamic acid (E) in the sequence of SEQ ID NO: 1.
Single-point mutants Q72E, N196D, T319E and multi-point mutants Q72E-N196D, N196D-T319E, Q72E-N196D-T319E of glycosyltransferase UGT76G1 (Unit prot ID: Q6VAB 4; Access: AY 345974).
An expressed gene encoding any of the glycosyltransferase mutants described above.
The nucleotide sequence of the 76G1_ Q72E mutant is shown as SEQ ID NO. 5, the nucleotide sequence of the 76G1_ N196D mutant is shown as SEQ ID NO. 6, the nucleotide sequence of the 76G1_ T319E mutant is shown as SEQ ID NO. 7, the nucleotide sequence of the 76G1_ Q72E-N196D mutant is shown as SEQ ID NO. 8, the nucleotide sequence of the 76G1_ N196D-T319E mutant is shown as SEQ ID NO. 9, and the nucleotide sequence of the 76G1_ Q72E-N196D-T319E mutant is shown as SEQ ID NO. 10.
A recombinant plasmid to which the above-described expression gene and sucrose synthase gene SUS are ligated.
A recombinant cell comprising an expression gene of the recombinant expression vector or the glycosyltransferase mutant.
The glycosyltransferase mutant is applied to preparing rebaudioside A.
A method for catalytically synthesizing rebaudioside a comprising the steps of:
1) constructing a recombinant strain containing a double-enzyme co-expression system: coexpression of the nucleotide sequence of the glycosyltransferase mutant and the nucleotide sequence of sucrose synthase to obtain recombinant plasmid, and transformation of the recombinant plasmid into competent cells of escherichia coli BL21(DE3) to obtain a recombinant strain containing a double-enzyme coexpression system;
2) induction of recombinant strains to produce enzymes: activating the recombinant strain, transferring the activated recombinant strain into a TB induction culture medium according to the proportion of 1-3%, culturing for about 2 hours at 37 ℃, reducing the temperature to 25 ℃ with the addition of lactose of 0.02g/L, continuing induction culture for 20 hours at 200rpm, centrifuging at low temperature and collecting thalli. The thalli is resuspended in a proper amount of buffer solution and crushed, and the supernatant fluid is collected by centrifugation to obtain crude enzyme solution;
3) catalytic synthesis of rebaudioside a: adding stevioside, cane sugar and crude enzyme liquid into a catalytic reaction system, reacting for 30 hours, inactivating the enzyme at high temperature, and centrifuging to obtain supernatant, namely rebaudioside-A.
The amino acid sequence of glycosyltransferase UGT76G1 is shown as SEQ ID NO. 1, the nucleotide sequence is shown as SEQ ID NO. 2, the amino acid sequence of sucrose synthase is shown as SEQ ID NO. 3, and the nucleotide sequence is shown as SEQ ID NO. 4. 76G1_ Q72E is shown as SEQ ID NO. 5, 76G1_ N196D is shown as SEQ ID NO. 6, 76G1_ T319E is shown as SEQ ID NO. 7, 76G1_ Q72E-N196D is shown as SEQ ID NO. 8, 76G1_ N196D-T319E is shown as SEQ ID NO. 9, and 76G1_ Q72E-N196D-T319E is shown as SEQ ID NO. 10.
The solubility of the protein is related to the hydrophilicity of surface residues, and the related amino acid residues on the surface of the protein are changed by utilizing a site-directed mutagenesis technology to improve the solubility of the protein. The contribution of the aspartic acid (D), the glutamic acid (E) and the serine (S) to the protein solubility is obviously higher than that of other hydrophilic amino acids, particularly under the condition of high net charge, the asparagine (N), the glutamine (Q) or the threonine (T) in the amino acid residues on the surface of the enzyme protein is replaced by D, E or S, the protein solubility expression level can be improved, and the high-efficiency catalysis of the enzyme can be promoted. According to the invention, based on glycosyltransferase UGT76G1, key amino acid site-directed mutagenesis is carried out on the surface residue of the glycosyltransferase UGT76G1, and the optimal glycosyltransferase mutant 76G1_ Q72E-N196D-T319E is obtained by comparing the relative activity and conversion rate of the mutant strain. The glycosyltransferase mutant is cascaded with sucrose synthase, stevioside is used as a substrate, a proper amount of sucrose is added, and rebaudioside A is catalytically synthesized. The mutant is simple to prepare, the high-efficiency catalytic synthesis of rebaudioside-A is realized, the activity of the mutant is improved by about 2.8 times compared with that of the original enzyme under the same condition, and the yield of rebaudioside-A is remarkably improved compared with that of the original enzyme. The catalytic effect of the reaction system based on the mutant strain 76G1_ Q72E-N196D-T319E is better than that of the non-mutant system, the concentration of RA glycoside is 20G/L when the reaction is carried out for 7 hours, and the catalytic rate is high.
According to the invention, the soluble expression of glycosyltransferase UGT76G1 and the enhancement of the hydrophobic acting force between the mutation site and the substrate are improved through mutation, the substrate conformation is drawn towards the glycosyl donor direction, the enzyme activity can be improved, the combination with the substrate stevioside is more suitable, and the rebaudioside A catalytic production efficiency is further improved.
Has the advantages that:
the invention improves the enzyme activity and soluble expression of glycosyltransferase UGT76G1 through site-directed mutagenesis, realizes high-efficiency catalytic synthesis of rebaudioside A by utilizing the mutant, and has the advantages of mild synthesis method conditions, simple operation, short time, high catalytic efficiency, high yield and better application prospect.
Drawings
FIG. 1UGT76G1 mutation site; the three stick structures are mutation points Asn196, Thr319 and Gln72 respectively.
Detailed Description
The technical solution of the present invention is further described below with reference to examples, but the scope of the present invention is not limited thereto.
The detection methods used in the following examples are as follows:
HPLC determination method:
the mobile phase was checked to be 80% acetonitrile and adjusted to pH 4.0 with glacial acetic acid. Filtering with a 0.45 mu m organic filter membrane, and removing bubbles by ultrasonic. The chromatographic column is BF-NH2, 5 μm 120A (Wuxi Jia Laike chromatography science and technology Co., Ltd.), the temperature of the chromatographic column is 40 ℃, the detection wavelength is 210 nm, and the detection time is 20 min. Filtration is required before all samples are detected (0.45 mu m organic filter membrane)
Methods for confirming mutants used in the following examples:
in the research, glycosyltransferase UGT76G1 is used for mutation, and the mutation of surface residue N, Q, T of the enzyme protein can improve the hydrophobicity and surface configuration between the enzyme structure and a substrate, improve the enzyme activity, and enhance the specific combination with the substrate, thereby greatly improving the catalytic effect. The replacement of N, Q, T in amino acid residues on the surface of the protein with D, E or S can effectively increase the soluble expression of the protein, and can make the substrate stevioside close to the sugar donor direction and increase the hydrophobic effect between the mutation site and the substrate. And the protein soluble expression is closely related to the relative enzyme activity of the protein. Therefore, the experiment starts from the surface residue Q, N, T of UGT76G1, the configuration of the binding reaction substrate is combined with the analysis results of the solvent accessible surface area, B-factor and other data (Table I), mutation sites of Asn196, Asn78, Asn400, Asn69, Gln72, Gln198, Gln178, Gln160, Thr319, Thr 81 and the like are further screened out on the basis of the obtained prediction, and then are mutated into Asp, Glu or Glu respectively, the relative activity of the mutated enzyme and the concentration of the rebaudioside A generated by conversion are compared, and better mutation sites are further screened out for iterative mutation, so that the biological method for efficiently and catalytically synthesizing rebaudioside A is realized.
EXAMPLE 1 preparation of glycosyltransferase mutants
PCR amplification of site-directed mutant coding gene: rapid mutation was carried out using PCR amplification technique with non-mutated strain pRSFDUet-UGT 76G1-AtSUS1 as template DNA:
the primers for site-directed mutagenesis of Q72E were:
a forward primer: 5' -AACGACCCGGAAGATGAACGCATCTCTAATCTGCCG-3' (the mutated base is underlined) is shown in SEQ ID NO:11
Reverse primer: 5' -GCGTTCATCTTCCGGGTCGTTATCCAGAATAAAACG-3' (the mutated base is underlined) is shown in SEQ ID NO:12
Primers for site-directed mutagenesis of N196D were:
a forward primer: 5' -GCGTACTCGGACTGGCAGATTCTGAAAGAAATCCTG-3' (the mutated base is underlined) is shown in SEQ ID NO:13
Reverse primer: 5' -AATCTGCCAGTCCGAGTACGCTGACTTAATATCCTT-3' (the mutated base is underlined) is shown in SEQ ID NO:14
Primers for site-directed mutagenesis of T319E were:
a forward primer: 5' -AAGGGCTCTGAATGGGTTGAACCGCTGCCGGACGGC-3' (the mutated base is underlined) is shown in SEQ ID NO:15
Reverse primer: 5' -TTCAACCCATTCAGAGCCCTTCACAAAACCCGGGCG-3' (the mutated base is underlined) is shown in SEQ ID NO:16
The PCR target plasmid amplification reaction system is as follows: 2. mu.L each of 10. mu.M forward and reverse primers; 1 μ L of dNTPmix; 2 × MaxBuffer 25 μ L; 1 μ L of template plasmid; 2U/50. mu.L Super-FidelityDNA polymerase 1. mu.L, sterile water dd H2O make up to 50. mu.L.
PCR target plasmid amplification reaction conditions: pre-denaturation at 95 ℃ for 30 s; 30 cycles (95 ℃ denaturation 15 s; 65 ℃ annealing 15 s; 72 ℃ extension 7 min); completely extending for 5min at 72 ℃; finally, keeping the temperature at 16 ℃. And carrying out agarose gel nucleic acid electrophoresis detection on the PCR amplification product.
Adding DpnI1 mu L into a PCR amplification product which is determined to have mutation, then placing a reaction system at 37 ℃ for constant temperature reaction for 1-2 h, transferring the reaction system into escherichia coli BL21(DE3) competent cells, placing the cells on ice for 30min, performing heat shock at 42 ℃ for 45-90 s, placing the cells on ice for 2min, adding 600 mu L of LB culture medium (formula: NaCl 10 g/L, yeast powder 5g/L, peptone 10 g/L), shaking the bed at 37 ℃ for 200rpm for 45min, taking all bacterial liquid, uniformly spreading the bacterial liquid on an LB plate containing kanamycin resistance, and performing overnight culture at 37 ℃.2 single colonies on the plate are picked, inoculated with LB liquid culture medium (formula: NaCl 10 g/L, yeast powder 5g/L, peptone 10 g/L), after 9h, a bacterial liquid glycerol tube is preserved and sequenced, the bacterial liquid glycerol tube with the correct sequencing result is coated on an LB plate (formula: NaCl 10 g/L, yeast powder 5g/L, peptone 10 g/L, agar 20 g/L) containing kanamycin resistance, the tube is shaken to activate and extract plasmids, and the recombinant plasmids are introduced into escherichia coli BL21(DE 3).
(1) Single point mutation
The mutant was obtained by introducing the recombinant plasmid into E.coli BL21(DE3) according to the site-directed mutagenesis method described above. The nucleotide sequence of the mutant 76G1_ Q72E is shown as SEQ ID NO. 5; the mutant 76G1_ N196D has the nucleotide sequence shown in SEQ ID NO 6; the mutant 76G1_ T319E has the nucleotide sequence shown in SEQ ID NO. 7.
Wherein, the amino acid sequence of glycosyltransferase UGT76G1 is shown in SEQ ID NO. 1, and the mutated amino acid sites are respectively selected from one of Gln72, Asn196 and Thr 319. The mutant Q72E is the amino acid 72 in the sequence of SEQ ID NO. 1, which is mutated from glutamine (Q) to glutamic acid (E); the mutant N196D is the mutant of the 196 th amino acid of SEQ ID NO. 1 sequence which is mutated from aspartyl (N) to aspartic acid (D); the mutant T319E is the amino acid 319 of the SEQ ID NO. 1 sequence mutated from threonine (T) to glutamic acid (E). The experimental results show that (Table 2), the relative enzyme activities of the 3 single-point mutants Q72E, N196D and T319E are all higher than that of UGT76G 1. The enzyme activity of the single-point mutant N196D is obviously higher than that of the mutants Q72E and T319E, and the single-point mutant N196D is about 1.5 times of the relative enzyme activity of an unmutated strain due to the increase of hydrophobic interaction before and after mutation.
(2) Multiple point mutation
On the basis of single-point mutation, overlapping Q72E and T319E on an effective mutation site N196D respectively to carry out double-point mutation and 3-point overlapping mutation to form a mutant 76G1_ Q72E-N196D which is shown as SEQ ID NO: 8; the mutant 76G1_ N196D-T319E is shown as SEQ ID NO 9; the mutant 76G1_ Q72E-N196D-T319E is shown as SEQ ID NO: 10.
Wherein, the amino acid sequence of glycosyltransferase UGT76G1 is shown in SEQ ID NO. 1, and the mutated amino acid sites are respectively selected from two or three of Gln72, Asn196 and Thr 319. The double-point mutant Q72E-N196D is SEQ ID NO:1, wherein the 72 th amino acid is mutated from glutamine (Q) to glutamic acid (E), and the 196 th amino acid is mutated from aspartyl (N) to aspartic acid (D); the double-point mutant N196D-T319E is SEQ ID NO. 1, wherein the 196 th amino acid is mutated from aspartyl (N) to aspartic acid (D), and the 319 th amino acid is mutated from threonine (T) to glutamic acid (E); the three-point mutant Q72E-N196D-T319E is characterized in that in the sequence of SEQ ID NO 1, the 72 th amino acid is mutated into glutamic acid (E) from glutamine (Q), the 196 th amino acid is mutated into aspartic acid (D) from aspartyl (N), and the 319 th amino acid is mutated into glutamic acid (E) from threonine (T); the results of the experiments (Table 3) show that all the multi-point mutants have higher relative enzyme activities than the non-mutant strains. In the double-point mutation, the relative enzyme activity of the double-point mutant Q72E-N196D is obviously higher than that of the double-point mutant N196D-T319E. The effect of the three-point combination mutant Q72E-N196D-T319E is superior to the relative enzyme activity of other two-point mutants N196D-T319E and Q72E-N196D, and the relative enzyme activity of the three-point combination mutant Q72E-N196D-T319E is about 2.8 times that of an unmutated strain. In conclusion, the relative enzyme activity of the multi-point mutant Q72E-N196D-T319E is highest. The recombinant strain 76G1_ Q72E-N196D-T319E containing three-point combined mutation shows increased hydrophobic interaction between a mutated site and a substrate in a cascade reaction, when the substrate concentration is increased to 30G/L and the crude enzyme concentration is 5mg/mL, the capacity of catalyzing and synthesizing RA glycoside by the mutant strain 76G1_ Q72E-N196D-T319E is obviously superior to that of an unmutated strain (Table 4) within 0-24 h, the yield of rebaudioside A is catalytically produced after 24h of reaction, and the yield of the mutant strain 76G1_ Q72E-N196D-T319E is 2.1 times that of the unmutated strain, so that the mutant strain 76G1_ Q72E-N196D-T319E can realize a high-efficiency catalytic synthesis method within a short time.
EXAMPLE 2 construction of the two-enzyme expression System
Selection of the Dual Gene expression vector pRSFDuet-1, on whichNdeI / XhoThe nucleotide sequence of glycosyltransferase UGT76G1 (Access: AY 345974) from stevia rebaudiana Bertoni or mutant nucleotide sequence thereof is inserted into the I siteNcoI/ EcoRI was inserted into the Arabidopsis-derived sucrose synthase AtSUS3 nucleotide sequence (Access: AY 051001) to construct a corresponding recombinant expression plasmid, and constructed into pRSFDuet-1 vector. The recombinant plasmid is introduced into Escherichia coli BL21(DE3) to form a double-enzyme co-expression recombinant strain.
Example 3 fermentation Induction of mutant enzymes
Recombinant bacteria constructed by single-point mutants Q72E, N196D and T319E of glycosyltransferase UGT76G1 (UniProt ID: Q6VAB 4) and multi-point mutants Q72E-N196D, N196D-T319E and Q72E-N196D-T319E are respectively coated on LB solid plates (NaCl 10G/L, yeast powder 5G/L, peptone 10G/L and agar 20G/L) containing 50 mu G/L kanamycin and are placed in a 37 ℃ incubator for overnight constant-temperature culture. The next day, single colonies were picked from the plates into shake tubes containing 5 mL of LB liquid medium (containing 50. mu.g/L kanamycin) and cultured overnight as seed liquid in a shaker at 37 ℃ and 200 rpm. The seed solution was inoculated into 100 mL TB medium (containing 50. mu.g/L kanamycin) at 1% (v: v). The mixture was placed in a shaker at 37 ℃ and 200rpm and cultured with shaking. After 2h, the temperature was adjusted to 25 ℃ and the culture was continued for 20-22 h.
The fermentation broth was collected and subjected to refrigerated centrifugation (4 ℃, 7000 rpm, 6 min), and the supernatant was discarded to obtain a sludge, which was washed twice with potassium phosphate buffer. Adding a proper amount of potassium phosphate buffer solution, placing in an ice water mixture, and ultrasonically crushing thalli by using an ultrasonic crusher, wherein the parameters are phi 6, 300W and 30 min. Centrifuging with refrigerated centrifuge at 4 deg.C and 8000rpm for 30min, collecting supernatant as crude enzyme solution, and storing in 4 deg.C refrigerator.
Example 4 method for determining the yield of a glycosyltransferase mutant coupled to a sucrose synthase
The method for measuring the enzyme activity of the glycosyltransferase comprises the following steps: enzyme catalyzed reaction at 3 mLAdding 1 mM substrate stevioside, 2 mM UDPG and 3 mM MgCl into the reaction system20.5 mg of crude enzyme, supplemented with 100 mM, pH 7.2 potassium phosphate buffer. The reaction conditions were 30 ℃ and the sampling time at 200rpm was 0min, 20 min, 30 min. Sample treatment: taking 500 mu L, boiling for 5min, centrifuging, taking the supernatant and n-butanol, extracting at a ratio of 1:1, filtering with an organic filter membrane (0.45 mu m), and placing in a sample bottle for HPLC detection. Definition of enzyme activity (U): the enzyme amount required for generating 1 mu mol of product by conversion within 1 minute is 1 enzyme activity unit.
The method for measuring the enzyme activity of the sucrose synthase comprises the following steps: 500 mM of sucrose as a substrate, 10 mM of UDP xNa and 3 mM of MgCl were added to 3 mL of the enzyme-catalyzed reaction system26 mg of crude enzyme, supplemented with 100 mM, pH 7.2 potassium phosphate buffer. The reaction conditions were 30 ℃, 200rpm, and the sampling time was 0min, 30min, 60 min. Sample treatment: boiling the sample for 5min, centrifuging to obtain 500 muL, adding 500 muL water, adding 2 mL DNS, boiling for 2min, cooling, adding 7 mL distilled water, and measuring A540Fructose content was calculated against DNS standard. Definition of enzyme activity (U): the enzyme amount required for generating 1 mu mol of product by conversion within 1 minute is 1 enzyme activity unit.
Catalytic reaction system (20 mL): substrate St glycoside 20 g/L, sucrose 60 g/L, crude enzyme 5mg/mL, supplemented with 100 mM, pH 7.2 potassium phosphate buffer. The catalytic reaction conditions were 30 ℃ and 200 rpm. Sampling according to a certain time, processing the sample, and detecting and analyzing by using High Performance Liquid Chromatography (HPLC). Sample treatment: diluting the sample to 20 times, boiling for 5min, centrifuging to obtain 500 muL, and adding n-butyl alcohol 1:1, extracting, filtering with an organic filter membrane (0.45 mu m), putting into a sample bottle, and waiting for HPLC detection and analysis.
EXAMPLE 5 comparison of the non-mutated strains with the optimal mutant for rebaudioside A Synthesis
And catalyzing a substrate stevioside to synthesize RA glycoside by using the unmutated strain and the optimal mutated strain 76G1_ Q72E-N196D-T319E under the same catalytic reaction condition, sampling within a certain time, and carrying out sample treatment and HPLC detection and analysis. Substrate St glycoside: the sucrose is 1: 3, the amount of crude enzyme added was 5mg/mL, supplemented with 100 mM, pH 7.2 potassium phosphate buffer, and the catalytic reaction conditions were 30 ℃ and 200 rpm. In the catalytic reaction in Table four, the addition amount of the substrate was 30g/L of St glycoside and 90 g/L of sucrose.
Table 1:
TABLE 1 analysis of parameters of the mutation sites
Amino acids Site of the body Two-stage structure Solvent accessible surface area (ASA, A)2) Pocket Channel Average B-factor (A)2) Hot spot
Asn(N) 196 extend strand(E) 80.66 1 1.2.4 62.99 ok
Asn(N) 78 3-10 helix(G) 154.36 3 - 69.73 ok
Asn(N) 400 bend(S) 107.42 - - 49.41 ok
Asn(N) 69 extend strand(E) 55.01 - - 35.83 ok
Gln(Q) 72 extend strand(E) 87.2 3 - 61.62 ok
Gln(Q) 198 alpha helix(H) 163.53 - 4 70.95 ok
Gln(Q) 178 extend strand(E) 121.26 - - 53.62 ok
Gln(Q) 160 alpha helix(H) 92.31 - - 53.56 ok
Thr(T) 319 extend strand(E) 109.25 24 - 52.57 ok
Thr(T) 81 extend strand(E) 92.43 3.4 3.5 47.7 ok
TABLE 2 relative enzyme Activity of Single Point mutations
Bacterial strains Relative enzyme activity (%)
Not mutated 100±9.0
76G1_Q72E 113.4±8.3
76G1_T319E 114.5±13.3
76G1_N196D 147.2±3.8
TABLE 3 relative enzyme Activity of multiple mutations
Bacterial strains Relative enzyme activity (%)
Not mutated 100±6.1
76G1_N196D-T319E 169.5±31.2
76G1_Q72E-N196D 264.4±61.4
76G1_Q72E-N196D-T319E 276.4±40.3
TABLE 4 comparison of the concentrations of RA glycosides catalytically synthesized by the mutant and the control group (stevioside substrate 30g/L, crude enzyme amount 5 mg/L)
Time (h) Control 76G1_Q72E-N196D-T319E
0 0.4 0.8
7 10.9 20.5
17 16.6 28.4
24 21.9 45.3
In the reaction of 24h, compared with the non-mutant strain, the mutant strain has the advantages that the catalytic synthesis rate of RA glycoside is obviously high, the final rebaudioside A concentration reaches 45g/L, and the rebaudioside A is efficiently catalytically synthesized.
Sequence listing
<110> Nanjing university of industry
<120> glycosyltransferase mutant and method for catalytically synthesizing rebaudioside-A by using same
<141> 2020-12-02
<160> 16
<170> SIPOSequenceListing 1.0
<210> 1
<211> 458
<212> PRT
<213> Artificial sequence (2 Ambystoma latex x Ambystoma jeffersonia)
<400> 1
Met Glu Asn Lys Thr Glu Thr Thr Val Arg Arg Arg Arg Arg Ile Ile
1 5 10 15
Leu Phe Pro Val Pro Phe Gln Gly His Ile Asn Pro Ile Leu Gln Leu
20 25 30
Ala Asn Val Leu Tyr Ser Lys Gly Phe Ser Ile Thr Ile Phe His Thr
35 40 45
Asn Phe Asn Lys Pro Lys Thr Ser Asn Tyr Pro His Phe Thr Phe Arg
50 55 60
Phe Ile Leu Asp Asn Asp Pro Gln Asp Glu Arg Ile Ser Asn Leu Pro
65 70 75 80
Thr His Gly Pro Leu Ala Gly Met Arg Ile Pro Ile Ile Asn Glu His
85 90 95
Gly Ala Asp Glu Leu Arg Arg Glu Leu Glu Leu Leu Met Leu Ala Ser
100 105 110
Glu Glu Asp Glu Glu Val Ser Cys Leu Ile Thr Asp Ala Leu Trp Tyr
115 120 125
Phe Ala Gln Ser Val Ala Asp Ser Leu Asn Leu Arg Arg Leu Val Leu
130 135 140
Met Thr Ser Ser Leu Phe Asn Phe His Ala His Val Ser Leu Pro Gln
145 150 155 160
Phe Asp Glu Leu Gly Tyr Leu Asp Pro Asp Asp Lys Thr Arg Leu Glu
165 170 175
Glu Gln Ala Ser Gly Phe Pro Met Leu Lys Val Lys Asp Ile Lys Ser
180 185 190
Ala Tyr Ser Asn Trp Gln Ile Leu Lys Glu Ile Leu Gly Lys Met Ile
195 200 205
Lys Gln Thr Lys Ala Ser Ser Gly Val Ile Trp Asn Ser Phe Lys Glu
210 215 220
Leu Glu Glu Ser Glu Leu Glu Thr Val Ile Arg Glu Ile Pro Ala Pro
225 230 235 240
Ser Phe Leu Ile Pro Leu Pro Lys His Leu Thr Ala Ser Ser Ser Ser
245 250 255
Leu Leu Asp His Asp Arg Thr Val Phe Gln Trp Leu Asp Gln Gln Pro
260 265 270
Pro Ser Ser Val Leu Tyr Val Ser Phe Gly Ser Thr Ser Glu Val Asp
275 280 285
Glu Lys Asp Phe Leu Glu Ile Ala Arg Gly Leu Val Asp Ser Lys Gln
290 295 300
Ser Phe Leu Trp Val Val Arg Pro Gly Phe Val Lys Gly Ser Thr Trp
305 310 315 320
Val Glu Pro Leu Pro Asp Gly Phe Leu Gly Glu Arg Gly Arg Ile Val
325 330 335
Lys Trp Val Pro Gln Gln Glu Val Leu Ala His Gly Ala Ile Gly Ala
340 345 350
Phe Trp Thr His Ser Gly Trp Asn Ser Thr Leu Glu Ser Val Cys Glu
355 360 365
Gly Val Pro Met Ile Phe Ser Asp Phe Gly Leu Asp Gln Pro Leu Asn
370 375 380
Ala Arg Tyr Met Ser Asp Val Leu Lys Val Gly Val Tyr Leu Glu Asn
385 390 395 400
Gly Trp Glu Arg Gly Glu Ile Ala Asn Ala Ile Arg Arg Val Met Val
405 410 415
Asp Glu Glu Gly Glu Tyr Ile Arg Gln Asn Ala Arg Val Leu Lys Gln
420 425 430
Lys Ala Asp Val Ser Leu Met Lys Gly Gly Ser Ser Tyr Glu Ser Leu
435 440 445
Glu Ser Leu Val Ser Tyr Ile Ser Ser Leu
450 455
<210> 2
<211> 1616
<212> DNA
<213> Artificial sequence (2 Ambystoma latex x Ambystoma jeffersonia)
<400> 2
cttgcgtgta aacgtcagtc aaacccaatg gaaaataaaa cggagaccac cgttcgccgg 60
cgccggagaa taatattatt cccggtacca tttcaaggcc acattaaccc aattcttcag 120
ctagccaatg tgttgtactc taaaggattc agtatcacca tctttcacac caacttcaac 180
aaacccaaaa catctaatta ccctcacttc actttcagat tcatcctcga caacgaccca 240
caagacgaac gcatttccaa tctaccgact catggtccgc tcgctggtat gcggattccg 300
attatcaacg aacacggagc tgacgaatta cgacgcgaac tggaactgtt gatgttagct 360
tctgaagaag atgaagaggt atcgtgttta atcacggatg ctctttggta cttcgcgcaa 420
tctgttgctg acagtcttaa cctccgacgg cttgttttga tgacaagcag cttgtttaat 480
tttcatgcac atgtttcact tcctcagttt gatgagcttg gttacctcga tcctgatgac 540
aaaacccgtt tggaagaaca agcgagtggg tttcctatgc taaaagtgaa agacatcaag 600
tctgcgtatt cgaactggca aatactcaaa gagatattag ggaagatgat aaaacaaaca 660
aaagcatctt caggagtcat ctggaactca tttaaggaac tcgaagagtc tgagctcgaa 720
actgttatcc gtgagatccc ggctccaagt ttcttgatac cactccccaa gcatttgaca 780
gcctcttcca gcagcttact agaccacgat cgaaccgttt ttcaatggtt agaccaacaa 840
ccgccaagtt cggtactgta tgttagtttt ggtagtacta gtgaagtgga tgagaaagat 900
ttcttggaaa tagctcgtgg gttggttgat agcaagcagt cgtttttatg ggtggttcga 960
cctgggtttg tcaagggttc gacgtgggtc gaaccgttgc cagatgggtt cttgggtgaa 1020
agaggacgta ttgtgaaatg ggttccacag caagaagtgc tagctcatgg agcaataggc 1080
gcattctgga ctcatagcgg atggaactct acgttggaaa gcgtttgtga aggtgttcct 1140
atgattttct cggattttgg gctcgatcaa ccgttgaatg ctagatacat gagtgatgtt 1200
ttgaaggtag gggtgtattt ggaaaatggg tgggaaagag gagagatagc aaatgcaata 1260
agaagagtta tggtggatga agaaggagaa tacattagac agaatgcaag agttttgaaa 1320
caaaaggcag atgtttcttt gatgaagggt ggttcgtctt acgaatcatt agagtctcta 1380
gtttcttaca tttcatcgtt gtaaataaca cgatgattaa tcaagcactt ggattgcatg 1440
ctagctgagt agctggtaat ttgagttatt agaagcaaag actacttggt ttaaattaaa 1500
taaaggatgg ttgttggtta tgtgagctag tttatgttat gttttgtagg ctataaaagc 1560
cttcatatgt ttcttattgt ttctgtttct aaggtgaaaa aaatgctcgt ttttat 1616
<210> 3
<211> 809
<212> PRT
<213> Artificial sequence (2 Ambystoma latex x Ambystoma jeffersonia)
<400> 3
Met Ala Asn Pro Lys Leu Thr Arg Val Leu Ser Thr Arg Asp Arg Val
1 5 10 15
Gln Asp Thr Leu Ser Ala His Arg Asn Glu Leu Val Ala Leu Leu Ser
20 25 30
Arg Tyr Val Asp Gln Gly Lys Gly Ile Leu Gln Pro His Asn Leu Ile
35 40 45
Asp Glu Leu Glu Ser Val Ile Gly Asp Asp Glu Thr Lys Lys Ser Leu
50 55 60
Ser Asp Gly Pro Phe Gly Glu Ile Leu Lys Ser Ala Met Glu Ala Ile
65 70 75 80
Val Val Pro Pro Phe Val Ala Leu Ala Val Arg Pro Arg Pro Gly Val
85 90 95
Trp Glu Tyr Val Arg Val Asn Val Phe Glu Leu Ser Val Glu Gln Leu
100 105 110
Thr Val Ser Glu Tyr Leu Arg Phe Lys Glu Glu Leu Val Asp Gly Pro
115 120 125
Asn Ser Asp Pro Phe Cys Leu Glu Leu Asp Phe Glu Pro Phe Asn Ala
130 135 140
Asn Val Pro Arg Pro Ser Arg Ser Ser Ser Ile Gly Asn Gly Val Gln
145 150 155 160
Phe Leu Asn Arg His Leu Ser Ser Val Met Phe Arg Asn Lys Asp Cys
165 170 175
Leu Glu Pro Leu Leu Asp Phe Leu Arg Val His Lys Tyr Lys Gly His
180 185 190
Pro Leu Met Leu Asn Asp Arg Ile Gln Ser Ile Ser Arg Leu Gln Ile
195 200 205
Gln Leu Ser Lys Ala Glu Asp His Ile Ser Lys Leu Ser Gln Glu Thr
210 215 220
Pro Phe Ser Glu Phe Glu Tyr Ala Leu Gln Gly Met Gly Phe Glu Lys
225 230 235 240
Gly Trp Gly Asp Thr Ala Gly Arg Val Leu Glu Met Met His Leu Leu
245 250 255
Ser Asp Ile Leu Gln Ala Pro Asp Pro Ser Ser Leu Glu Lys Phe Leu
260 265 270
Gly Met Val Pro Met Val Phe Asn Val Val Ile Leu Ser Pro His Gly
275 280 285
Tyr Phe Gly Gln Ala Asn Val Leu Gly Leu Pro Asp Thr Gly Gly Gln
290 295 300
Val Val Tyr Ile Leu Asp Gln Val Arg Ala Leu Glu Thr Glu Met Leu
305 310 315 320
Leu Arg Ile Lys Arg Gln Gly Leu Asp Ile Ser Pro Ser Ile Leu Ile
325 330 335
Val Thr Arg Leu Ile Pro Asp Ala Lys Gly Thr Thr Cys Asn Gln Arg
340 345 350
Leu Glu Arg Val Ser Gly Thr Glu His Thr His Ile Leu Arg Val Pro
355 360 365
Phe Arg Ser Glu Lys Gly Ile Leu Arg Lys Trp Ile Ser Arg Phe Asp
370 375 380
Val Trp Pro Tyr Leu Glu Asn Tyr Ala Gln Asp Ala Ala Ser Glu Ile
385 390 395 400
Val Gly Glu Leu Gln Gly Val Pro Asp Phe Ile Ile Gly Asn Tyr Ser
405 410 415
Asp Gly Asn Leu Val Ala Ser Leu Met Ala His Arg Met Gly Val Thr
420 425 430
Gln Cys Thr Ile Ala His Ala Leu Glu Lys Thr Lys Tyr Pro Asp Ser
435 440 445
Asp Ile Tyr Trp Lys Asp Phe Asp Asn Lys Tyr His Phe Ser Cys Gln
450 455 460
Phe Thr Ala Asp Leu Ile Ala Met Asn Asn Ala Asp Phe Ile Ile Thr
465 470 475 480
Ser Thr Tyr Gln Glu Ile Ala Gly Thr Lys Asn Thr Val Gly Gln Tyr
485 490 495
Glu Ser His Gly Ala Phe Thr Leu Pro Gly Leu Tyr Arg Val Val His
500 505 510
Gly Ile Asp Val Phe Asp Pro Lys Phe Asn Ile Val Ser Pro Gly Ala
515 520 525
Asp Met Thr Ile Tyr Phe Pro Tyr Ser Glu Glu Thr Arg Arg Leu Thr
530 535 540
Ala Leu His Gly Ser Ile Glu Glu Met Leu Tyr Ser Pro Asp Gln Thr
545 550 555 560
Asp Glu His Val Gly Thr Leu Ser Asp Arg Ser Lys Pro Ile Leu Phe
565 570 575
Ser Met Ala Arg Leu Asp Lys Val Lys Asn Ile Ser Gly Leu Val Glu
580 585 590
Met Tyr Ser Lys Asn Thr Lys Leu Arg Glu Leu Val Asn Leu Val Val
595 600 605
Ile Ala Gly Asn Ile Asp Val Asn Lys Ser Lys Asp Arg Glu Glu Ile
610 615 620
Val Glu Ile Glu Lys Met His Asn Leu Met Lys Asn Tyr Lys Leu Asp
625 630 635 640
Gly Gln Phe Arg Trp Ile Thr Ala Gln Thr Asn Arg Ala Arg Asn Gly
645 650 655
Glu Leu Tyr Arg Tyr Ile Ala Asp Thr Arg Gly Ala Phe Ala Gln Pro
660 665 670
Ala Phe Tyr Glu Ala Phe Gly Leu Thr Val Val Glu Ala Met Thr Cys
675 680 685
Gly Leu Pro Thr Phe Ala Thr Cys His Gly Gly Pro Ala Glu Ile Ile
690 695 700
Glu His Gly Leu Ser Gly Phe His Ile Asp Pro Tyr His Pro Glu Gln
705 710 715 720
Ala Gly Asn Ile Met Ala Asp Phe Phe Glu Arg Cys Lys Glu Asp Pro
725 730 735
Asn His Trp Lys Lys Val Ser Asp Ala Gly Leu Gln Arg Ile Tyr Glu
740 745 750
Arg Tyr Thr Trp Lys Ile Tyr Ser Glu Arg Leu Met Thr Leu Ala Gly
755 760 765
Val Tyr Gly Phe Trp Lys Tyr Val Ser Lys Leu Glu Arg Arg Glu Thr
770 775 780
Arg Arg Tyr Leu Glu Met Phe Tyr Ile Leu Lys Phe Arg Asp Leu Val
785 790 795 800
Lys Thr Val Pro Ser Thr Ala Asp Asp
805
<210> 4
<211> 2904
<212> DNA
<213> Artificial sequence (2 Ambystoma latex x Ambystoma jeffersonia)
<400> 4
acgtcacttg tagcgaaaac agtatcaaga aaaagagaag atcaaacacg tcttcttttc 60
tctctctctc tttgtcgcct aaaattccag aatcactctg ctttttaccc ttttaatcaa 120
tgatttttcc ttttagtagc aatcgttggt gattcgaaaa accaaacttt tctcggacta 180
ggattctagg gttttagtga tcatctgaat attcatggca aaccctaagc tcactagggt 240
tctaagcaca agggatcgcg tgcaagacac gctttccgct caccgcaacg aactcgttgc 300
tcttctctcc aggtatgtgg atcaggggaa agggattctt caaccacata acttaattga 360
cgaactcgaa tctgttatcg gagacgatga aacaaagaag agtctctctg atggtccttt 420
tggagagatc cttaaatcag caatggaagc tatagttgta ccaccttttg ttgcgttagc 480
cgttagacca agacctggtg tttgggaata tgttcgtgtt aatgtcttcg agctaagtgt 540
tgaacaatta acagtctctg agtatcttcg tttcaaagaa gaactcgttg atggacctaa 600
tagtgaccct ttttgtcttg agcttgattt cgagcccttt aacgcaaacg tgccacgtcc 660
ttctcgttcg tcttcgattg gtaatggagt tcagtttctg aatcgtcact tgtcttctgt 720
tatgttccgt aacaaagatt gcttggagcc tctgcttgat ttccttagag ttcataagta 780
caaaggtcat ccgttgatgt tgaatgatcg gattcaaagc atatctaggc ttcaaatcca 840
gcttagtaaa gcagaagatc atatctctaa gctttcacaa gaaactccgt tctcggaatt 900
cgaatacgcg ttgcaaggaa tgggttttga gaaaggatgg ggagataccg cagggagagt 960
tcttgaaatg atgcatcttc tctctgatat tcttcaagct cctgatcctt cgtccttgga 1020
gaagtttctt gggatggtac caatggtttt caacgttgtg atcttatctc cacatggata 1080
tttcgggcaa gccaatgttt taggcttacc tgacactggt ggacaagttg tctatattct 1140
tgaccaagtc cgtgcccttg agactgaaat gctgttgaga ataaagagac aggggttgga 1200
tatatcacct agtattctta ttgtaactag gttgataccg gatgctaaag gaactacgtg 1260
taaccagcgg ttagagagag tcagcggaac agagcatact catattctcc gggttccttt 1320
taggtctgag aaaggaatcc tccgtaagtg gatttcaaga ttcgacgtat ggccttatct 1380
agagaactat gctcaggatg cagcaagcga gattgtcggt gaattgcaag gcgtaccgga 1440
ctttatcatc ggtaactata gtgacggaaa ccttgttgca tcgttaatgg cacatagaat 1500
gggtgttaca caatgtacta ttgcacatgc tttggagaaa accaagtatc cagattcaga 1560
catttactgg aaagacttcg acaacaagta tcatttctct tgtcaattca cagctgatct 1620
tatcgcaatg aacaacgcag atttcatcat cacaagcact taccaagaaa tcgcaggaac 1680
gaagaacacc gtcggtcaat atgaaagcca cggggctttt acgctcccgg gactatatag 1740
agtagtacac ggcatcgatg tgtttgatcc gaagttcaac atagtctcgc ccggtgcaga 1800
catgaccata tatttcccgt attccgaaga aactaggaga cttacagctt tacatggttc 1860
aatagaggaa atgctctata gccctgacca gactgatgag catgtcggta cactgagtga 1920
tcgatcaaag ccaatactct tctctatggc gaggctcgac aaagtgaaga acatctccgg 1980
tttagttgag atgtatagta agaacacaaa gttgagggag ctggttaatc tggttgtaat 2040
agctggtaac attgatgtga acaagtccaa agatagagaa gaaatcgtag agattgagaa 2100
aatgcataac cttatgaaga attacaagct tgatggacag tttcgttgga taactgctca 2160
gactaaccga gctcgaaatg gtgagcttta ccgctacatc gcggatacaa gaggtgcttt 2220
tgctcagcct gcgttctacg aggcttttgg acttacggta gtggaagcga tgacttgcgg 2280
gctcccgact tttgccactt gtcacggtgg tccagcagag atcatcgagc acgggctctc 2340
gggtttccac atcgatccat accatcctga gcaagcgggt aacataatgg ctgatttctt 2400
tgaacgttgt aaggaagatc caaaccattg gaagaaagta tcagacgctg gtctccaaag 2460
gatatacgaa aggtacacat ggaagatata ctcggagaga ttgatgacac tagctggtgt 2520
gtatggtttc tggaaatacg tatcgaaatt ggagcgtcgt gagactcggc gatatcttga 2580
aatgttctac attctcaaat tccgcgactt ggtgaaaact gttccttcaa ccgccgatga 2640
ctgacccggt tcagcgttgg atgaagtgtt ggactgtaaa aaagaataaa tgatgagtaa 2700
ctttggctat gtaccctatg ttgtgtgtat gtatgaaagg aagaatttgt tccatcttcc 2760
atggagtaat tacgaatttg gtggtacttt tgtgttgtct catgtgtgtc tgactgacat 2820
gttgaagatt attcacgtga agtttgtagc ttataataaa aagtcttcaa tggaacattt 2880
catttcacaa aaaaaaaaaa aaaa 2904
<210> 5
<211> 1437
<212> DNA
<213> Artificial sequence (2 Ambystoma latex x Ambystoma jeffersonia)
<400> 5
atgggcagca gccatcatca tcatcatcac agcagcggcc tggtgccgcg cggcagccat 60
atggaaaata aaaccgaaac caccgtccgc cgtcgtcgcc gtatcattct gttcccggtc 120
ccgttccagg gccacatcaa cccgattctg caactggcga acgtgctgta ttcgaaaggt 180
ttcagcatca ccatcttcca tacgaacttc aacaagccga agaccagcaa ttacccgcac 240
tttacgttcc gttttattct ggataacgac ccggaagatg aacgcatctc taatctgccg 300
acccacggcc cgctggcggg tatgcgtatt ccgattatca acgaacacgg cgcagatgaa 360
ctgcgtcgcg aactggaact gctgatgctg gccagcgaag aagatgaaga agtttcttgc 420
ctgatcaccg acgcactgtg gtattttgcc cagtctgttg cagatagtct gaacctgcgt 480
cgcctggtcc tgatgaccag cagcctgttc aattttcatg cccacgttag tctgccgcag 540
ttcgatgaac tgggttatct ggacccggat gacaaaaccc gcctggaaga acaggcgagc 600
ggctttccga tgctgaaagt caaggatatt aagtcagcgt actcgaactg gcagattctg 660
aaagaaatcc tgggtaaaat gattaagcaa accaaagcaa gttccggcgt catctggaat 720
agtttcaaag aactggaaga atccgaactg gaaacggtga ttcgtgaaat cccggctccg 780
agttttctga ttccgctgcc gaagcatctg accgcgagca gcagcagcct gctggatcac 840
gaccgcacgg tgtttcagtg gctggatcag caaccgccga gttccgtgct gtatgttagc 900
ttcggtagta cctcggaagt ggatgaaaag gactttctgg aaatcgctcg tggcctggtt 960
gatagcaaac aatctttcct gtgggtggtt cgcccgggtt ttgtgaaggg ctctacgtgg 1020
gttgaaccgc tgccggacgg cttcctgggt gaacgtggcc gcattgtcaa atgggtgccg 1080
cagcaagaag tgctggcgca tggcgcgatt ggcgcgtttt ggacccactc cggttggaac 1140
tcaacgctgg aatcggtttg tgaaggtgtc ccgatgattt tctcagattt tggcctggac 1200
cagccgctga atgcacgtta tatgtcggat gttctgaaag tcggtgtgta cctggaaaac 1260
ggttgggaac gcggcgaaat tgcgaatgcc atccgtcgcg ttatggtcga tgaagaaggc 1320
gaatacattc gtcagaatgc tcgcgtcctg aaacaaaagg cggacgtgag cctgatgaaa 1380
ggcggttcat cgtatgaaag tctggaatcc ctggtttcat acatcagctc tctgtaa 1437
<210> 6
<211> 1437
<212> DNA
<213> Artificial sequence (2 Ambystoma latex x Ambystoma jeffersonia)
<400> 6
atgggcagca gccatcatca tcatcatcac agcagcggcc tggtgccgcg cggcagccat 60
atggaaaata aaaccgaaac caccgtccgc cgtcgtcgcc gtatcattct gttcccggtc 120
ccgttccagg gccacatcaa cccgattctg caactggcga acgtgctgta ttcgaaaggt 180
ttcagcatca ccatcttcca tacgaacttc aacaagccga agaccagcaa ttacccgcac 240
tttacgttcc gttttattct ggataacgac ccgcaggatg aacgcatctc taatctgccg 300
acccacggcc cgctggcggg tatgcgtatt ccgattatca acgaacacgg cgcagatgaa 360
ctgcgtcgcg aactggaact gctgatgctg gccagcgaag aagatgaaga agtttcttgc 420
ctgatcaccg acgcactgtg gtattttgcc cagtctgttg cagatagtct gaacctgcgt 480
cgcctggtcc tgatgaccag cagcctgttc aattttcatg cccacgttag tctgccgcag 540
ttcgatgaac tgggttatct ggacccggat gacaaaaccc gcctggaaga acaggcgagc 600
ggctttccga tgctgaaagt caaggatatt aagtcagcgt actcggactg gcagattctg 660
aaagaaatcc tgggtaaaat gattaagcaa accaaagcaa gttccggcgt catctggaat 720
agtttcaaag aactggaaga atccgaactg gaaacggtga ttcgtgaaat cccggctccg 780
agttttctga ttccgctgcc gaagcatctg accgcgagca gcagcagcct gctggatcac 840
gaccgcacgg tgtttcagtg gctggatcag caaccgccga gttccgtgct gtatgttagc 900
ttcggtagta cctcggaagt ggatgaaaag gactttctgg aaatcgctcg tggcctggtt 960
gatagcaaac aatctttcct gtgggtggtt cgcccgggtt ttgtgaaggg ctctacgtgg 1020
gttgaaccgc tgccggacgg cttcctgggt gaacgtggcc gcattgtcaa atgggtgccg 1080
cagcaagaag tgctggcgca tggcgcgatt ggcgcgtttt ggacccactc cggttggaac 1140
tcaacgctgg aatcggtttg tgaaggtgtc ccgatgattt tctcagattt tggcctggac 1200
cagccgctga atgcacgtta tatgtcggat gttctgaaag tcggtgtgta cctggaaaac 1260
ggttgggaac gcggcgaaat tgcgaatgcc atccgtcgcg ttatggtcga tgaagaaggc 1320
gaatacattc gtcagaatgc tcgcgtcctg aaacaaaagg cggacgtgag cctgatgaaa 1380
ggcggttcat cgtatgaaag tctggaatcc ctggtttcat acatcagctc tctgtaa 1437
<210> 7
<211> 1437
<212> DNA
<213> Artificial sequence (2 Ambystoma latex x Ambystoma jeffersonia)
<400> 7
atgggcagca gccatcatca tcatcatcac agcagcggcc tggtgccgcg cggcagccat 60
atggaaaata aaaccgaaac caccgtccgc cgtcgtcgcc gtatcattct gttcccggtc 120
ccgttccagg gccacatcaa cccgattctg caactggcga acgtgctgta ttcgaaaggt 180
ttcagcatca ccatcttcca tacgaacttc aacaagccga agaccagcaa ttacccgcac 240
tttacgttcc gttttattct ggataacgac ccgcaggatg aacgcatctc taatctgccg 300
acccacggcc cgctggcggg tatgcgtatt ccgattatca acgaacacgg cgcagatgaa 360
ctgcgtcgcg aactggaact gctgatgctg gccagcgaag aagatgaaga agtttcttgc 420
ctgatcaccg acgcactgtg gtattttgcc cagtctgttg cagatagtct gaacctgcgt 480
cgcctggtcc tgatgaccag cagcctgttc aattttcatg cccacgttag tctgccgcag 540
ttcgatgaac tgggttatct ggacccggat gacaaaaccc gcctggaaga acaggcgagc 600
ggctttccga tgctgaaagt caaggatatt aagtcagcgt actcgaactg gcagattctg 660
aaagaaatcc tgggtaaaat gattaagcaa accaaagcaa gttccggcgt catctggaat 720
agtttcaaag aactggaaga atccgaactg gaaacggtga ttcgtgaaat cccggctccg 780
agttttctga ttccgctgcc gaagcatctg accgcgagca gcagcagcct gctggatcac 840
gaccgcacgg tgtttcagtg gctggatcag caaccgccga gttccgtgct gtatgttagc 900
ttcggtagta cctcggaagt ggatgaaaag gactttctgg aaatcgctcg tggcctggtt 960
gatagcaaac aatctttcct gtgggtggtt cgcccgggtt ttgtgaaggg ctctgaatgg 1020
gttgaaccgc tgccggacgg cttcctgggt gaacgtggcc gcattgtcaa atgggtgccg 1080
cagcaagaag tgctggcgca tggcgcgatt ggcgcgtttt ggacccactc cggttggaac 1140
tcaacgctgg aatcggtttg tgaaggtgtc ccgatgattt tctcagattt tggcctggac 1200
cagccgctga atgcacgtta tatgtcggat gttctgaaag tcggtgtgta cctggaaaac 1260
ggttgggaac gcggcgaaat tgcgaatgcc atccgtcgcg ttatggtcga tgaagaaggc 1320
gaatacattc gtcagaatgc tcgcgtcctg aaacaaaagg cggacgtgag cctgatgaaa 1380
ggcggttcat cgtatgaaag tctggaatcc ctggtttcat acatcagctc tctgtaa 1437
<210> 8
<211> 1437
<212> DNA
<213> Artificial sequence (2 Ambystoma latex x Ambystoma jeffersonia)
<400> 8
atgggcagca gccatcatca tcatcatcac agcagcggcc tggtgccgcg cggcagccat 60
atggaaaata aaaccgaaac caccgtccgc cgtcgtcgcc gtatcattct gttcccggtc 120
ccgttccagg gccacatcaa cccgattctg caactggcga acgtgctgta ttcgaaaggt 180
ttcagcatca ccatcttcca tacgaacttc aacaagccga agaccagcaa ttacccgcac 240
tttacgttcc gttttattct ggataacgac ccggaagatg aacgcatctc taatctgccg 300
acccacggcc cgctggcggg tatgcgtatt ccgattatca acgaacacgg cgcagatgaa 360
ctgcgtcgcg aactggaact gctgatgctg gccagcgaag aagatgaaga agtttcttgc 420
ctgatcaccg acgcactgtg gtattttgcc cagtctgttg cagatagtct gaacctgcgt 480
cgcctggtcc tgatgaccag cagcctgttc aattttcatg cccacgttag tctgccgcag 540
ttcgatgaac tgggttatct ggacccggat gacaaaaccc gcctggaaga acaggcgagc 600
ggctttccga tgctgaaagt caaggatatt aagtcagcgt actcggactg gcagattctg 660
aaagaaatcc tgggtaaaat gattaagcaa accaaagcaa gttccggcgt catctggaat 720
agtttcaaag aactggaaga atccgaactg gaaacggtga ttcgtgaaat cccggctccg 780
agttttctga ttccgctgcc gaagcatctg accgcgagca gcagcagcct gctggatcac 840
gaccgcacgg tgtttcagtg gctggatcag caaccgccga gttccgtgct gtatgttagc 900
ttcggtagta cctcggaagt ggatgaaaag gactttctgg aaatcgctcg tggcctggtt 960
gatagcaaac aatctttcct gtgggtggtt cgcccgggtt ttgtgaaggg ctctacgtgg 1020
gttgaaccgc tgccggacgg cttcctgggt gaacgtggcc gcattgtcaa atgggtgccg 1080
cagcaagaag tgctggcgca tggcgcgatt ggcgcgtttt ggacccactc cggttggaac 1140
tcaacgctgg aatcggtttg tgaaggtgtc ccgatgattt tctcagattt tggcctggac 1200
cagccgctga atgcacgtta tatgtcggat gttctgaaag tcggtgtgta cctggaaaac 1260
ggttgggaac gcggcgaaat tgcgaatgcc atccgtcgcg ttatggtcga tgaagaaggc 1320
gaatacattc gtcagaatgc tcgcgtcctg aaacaaaagg cggacgtgag cctgatgaaa 1380
ggcggttcat cgtatgaaag tctggaatcc ctggtttcat acatcagctc tctgtaa 1437
<210> 9
<211> 1437
<212> DNA
<213> Artificial sequence (2 Ambystoma latex x Ambystoma jeffersonia)
<400> 9
atgggcagca gccatcatca tcatcatcac agcagcggcc tggtgccgcg cggcagccat 60
atggaaaata aaaccgaaac caccgtccgc cgtcgtcgcc gtatcattct gttcccggtc 120
ccgttccagg gccacatcaa cccgattctg caactggcga acgtgctgta ttcgaaaggt 180
ttcagcatca ccatcttcca tacgaacttc aacaagccga agaccagcaa ttacccgcac 240
tttacgttcc gttttattct ggataacgac ccgcaggatg aacgcatctc taatctgccg 300
acccacggcc cgctggcggg tatgcgtatt ccgattatca acgaacacgg cgcagatgaa 360
ctgcgtcgcg aactggaact gctgatgctg gccagcgaag aagatgaaga agtttcttgc 420
ctgatcaccg acgcactgtg gtattttgcc cagtctgttg cagatagtct gaacctgcgt 480
cgcctggtcc tgatgaccag cagcctgttc aattttcatg cccacgttag tctgccgcag 540
ttcgatgaac tgggttatct ggacccggat gacaaaaccc gcctggaaga acaggcgagc 600
ggctttccga tgctgaaagt caaggatatt aagtcagcgt actcggactg gcagattctg 660
aaagaaatcc tgggtaaaat gattaagcaa accaaagcaa gttccggcgt catctggaat 720
agtttcaaag aactggaaga atccgaactg gaaacggtga ttcgtgaaat cccggctccg 780
agttttctga ttccgctgcc gaagcatctg accgcgagca gcagcagcct gctggatcac 840
gaccgcacgg tgtttcagtg gctggatcag caaccgccga gttccgtgct gtatgttagc 900
ttcggtagta cctcggaagt ggatgaaaag gactttctgg aaatcgctcg tggcctggtt 960
gatagcaaac aatctttcct gtgggtggtt cgcccgggtt ttgtgaaggg ctctgaatgg 1020
gttgaaccgc tgccggacgg cttcctgggt gaacgtggcc gcattgtcaa atgggtgccg 1080
cagcaagaag tgctggcgca tggcgcgatt ggcgcgtttt ggacccactc cggttggaac 1140
tcaacgctgg aatcggtttg tgaaggtgtc ccgatgattt tctcagattt tggcctggac 1200
cagccgctga atgcacgtta tatgtcggat gttctgaaag tcggtgtgta cctggaaaac 1260
ggttgggaac gcggcgaaat tgcgaatgcc atccgtcgcg ttatggtcga tgaagaaggc 1320
gaatacattc gtcagaatgc tcgcgtcctg aaacaaaagg cggacgtgag cctgatgaaa 1380
ggcggttcat cgtatgaaag tctggaatcc ctggtttcat acatcagctc tctgtaa 1437
<210> 10
<211> 1437
<212> DNA
<213> Artificial sequence (2 Ambystoma latex x Ambystoma jeffersonia)
<400> 10
atgggcagca gccatcatca tcatcatcac agcagcggcc tggtgccgcg cggcagccat 60
atggaaaata aaaccgaaac caccgtccgc cgtcgtcgcc gtatcattct gttcccggtc 120
ccgttccagg gccacatcaa cccgattctg caactggcga acgtgctgta ttcgaaaggt 180
ttcagcatca ccatcttcca tacgaacttc aacaagccga agaccagcaa ttacccgcac 240
tttacgttcc gttttattct ggataacgac ccggaagatg aacgcatctc taatctgccg 300
acccacggcc cgctggcggg tatgcgtatt ccgattatca acgaacacgg cgcagatgaa 360
ctgcgtcgcg aactggaact gctgatgctg gccagcgaag aagatgaaga agtttcttgc 420
ctgatcaccg acgcactgtg gtattttgcc cagtctgttg cagatagtct gaacctgcgt 480
cgcctggtcc tgatgaccag cagcctgttc aattttcatg cccacgttag tctgccgcag 540
ttcgatgaac tgggttatct ggacccggat gacaaaaccc gcctggaaga acaggcgagc 600
ggctttccga tgctgaaagt caaggatatt aagtcagcgt actcggactg gcagattctg 660
aaagaaatcc tgggtaaaat gattaagcaa accaaagcaa gttccggcgt catctggaat 720
agtttcaaag aactggaaga atccgaactg gaaacggtga ttcgtgaaat cccggctccg 780
agttttctga ttccgctgcc gaagcatctg accgcgagca gcagcagcct gctggatcac 840
gaccgcacgg tgtttcagtg gctggatcag caaccgccga gttccgtgct gtatgttagc 900
ttcggtagta cctcggaagt ggatgaaaag gactttctgg aaatcgctcg tggcctggtt 960
gatagcaaac aatctttcct gtgggtggtt cgcccgggtt ttgtgaaggg ctctgaatgg 1020
gttgaaccgc tgccggacgg cttcctgggt gaacgtggcc gcattgtcaa atgggtgccg 1080
cagcaagaag tgctggcgca tggcgcgatt ggcgcgtttt ggacccactc cggttggaac 1140
tcaacgctgg aatcggtttg tgaaggtgtc ccgatgattt tctcagattt tggcctggac 1200
cagccgctga atgcacgtta tatgtcggat gttctgaaag tcggtgtgta cctggaaaac 1260
ggttgggaac gcggcgaaat tgcgaatgcc atccgtcgcg ttatggtcga tgaagaaggc 1320
gaatacattc gtcagaatgc tcgcgtcctg aaacaaaagg cggacgtgag cctgatgaaa 1380
ggcggttcat cgtatgaaag tctggaatcc ctggtttcat acatcagctc tctgtaa 1437
<210> 11
<211> 36
<212> DNA
<213> Artificial sequence (2 Ambystoma latex x Ambystoma jeffersonia)
<400> 11
aacgacccgg aagatgaacg catctctaat ctgccg 36
<210> 12
<211> 36
<212> DNA
<213> Artificial sequence (2 Ambystoma latex x Ambystoma jeffersonia)
<400> 12
gcgttcatct tccgggtcgt tatccagaat aaaacg 36
<210> 13
<211> 36
<212> DNA
<213> Artificial sequence (2 Ambystoma latex x Ambystoma jeffersonia)
<400> 13
gcgtactcgg actggcagat tctgaaagaa atcctg 36
<210> 14
<211> 36
<212> DNA
<213> Artificial sequence (2 Ambystoma latex x Ambystoma jeffersonia)
<400> 14
aatctgccag tccgagtacg ctgacttaat atcctt 36
<210> 15
<211> 36
<212> DNA
<213> Artificial sequence (2 Ambystoma latex x Ambystoma jeffersonia)
<400> 15
aagggctctg aatgggttga accgctgccg gacggc 36
<210> 16
<211> 36
<212> DNA
<213> Artificial sequence (2 Ambystoma latex x Ambystoma jeffersonia)
<400> 16
ttcaacccat tcagagccct tcacaaaacc cgggcg 36

Claims (8)

1. A glycosyltransferase mutant characterized in that the mutant is an amino acid sequence mutated on the basis of the amino acid sequence of the glycosyltransferase shown as SEQ ID NO. 1, and the mutation is any single-point or multi-point mutation of Asn196, Asn78, Asn400, Asn69, Gln72, Gln198, Gln178, Gln160, Thr319 or Thr 81.
2. The glycosyltransferase mutant of claim 1, wherein the mutation is a Q72E-N196D-T319E multiple point stacking mutation.
3. An expressed gene encoding the glycosyltransferase mutant of claim 1.
4. A recombinant plasmid to which the expressible gene of claim 3 is linked.
5. A recombinant cell comprising an expression gene of the recombinant expression plasmid or the glycosyltransferase mutant.
6. A method for catalytically synthesizing rebaudioside A by utilizing a glycosyltransferase mutant is characterized by comprising the following steps:
1) constructing a recombinant strain containing double-enzyme coexpression: constructing genes of the mutant of glycosyltransferase UGT76G1 and sucrose synthase genes into plasmids to obtain recombinant plasmids;
2) transforming the recombinant plasmid into a competent cell of escherichia coli BL21(DE3) to obtain a recombinant strain containing a double-enzyme co-expression system;
3) activating the recombinant strain, transferring the recombinant strain to a TB induction culture medium, adding an inducer for induction culture, centrifuging at low temperature and collecting thalli, suspending the thalli in a proper amount of buffer solution and crushing, centrifuging and collecting supernatant, namely crude enzyme solution;
4) catalytic synthesis of rebaudioside a: adding stevioside, cane sugar and crude enzyme liquid into a catalytic reaction system, reacting for 5-30h, inactivating the enzyme at high temperature, and centrifuging to obtain supernatant, namely rebaudioside-A.
7. The method of claim 6, wherein the final concentration of the inducer is 0.02g/L and the induction time is 20 h.
8. The method of claim 6, wherein the concentration of stevioside is 30 g/L; the concentration of the sucrose is 90 g/L; the amount of the crude enzyme added was 5 g/L.
CN202011388873.6A 2020-12-02 2020-12-02 Glycosyltransferase mutant and method for catalytically synthesizing rebaudioside A by using same Active CN112375750B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011388873.6A CN112375750B (en) 2020-12-02 2020-12-02 Glycosyltransferase mutant and method for catalytically synthesizing rebaudioside A by using same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011388873.6A CN112375750B (en) 2020-12-02 2020-12-02 Glycosyltransferase mutant and method for catalytically synthesizing rebaudioside A by using same

Publications (2)

Publication Number Publication Date
CN112375750A true CN112375750A (en) 2021-02-19
CN112375750B CN112375750B (en) 2022-06-03

Family

ID=74589646

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011388873.6A Active CN112375750B (en) 2020-12-02 2020-12-02 Glycosyltransferase mutant and method for catalytically synthesizing rebaudioside A by using same

Country Status (1)

Country Link
CN (1) CN112375750B (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113462670A (en) * 2021-08-23 2021-10-01 南京工业大学 Glycosyltransferase mutant and method for catalytically synthesizing rebaudioside M by using same
CN114875007A (en) * 2022-06-29 2022-08-09 上海交通大学 Glycosyltransferase mutant with improved heat and organic solvent stability
CN115404226A (en) * 2021-05-27 2022-11-29 南京工业大学 Sucrose synthase and application thereof in catalytic glycosylation reaction
CN115418358A (en) * 2021-06-01 2022-12-02 弈柯莱生物科技(上海)股份有限公司 Glycosyl transferase and application thereof
WO2022257983A1 (en) * 2021-06-08 2022-12-15 弈柯莱生物科技(上海)股份有限公司 β-1,2-GLYCOSYLTRANSFERASE, AND APPLICATION THEREOF
CN115478060A (en) * 2021-06-16 2022-12-16 弈柯莱生物科技(上海)股份有限公司 Glycosyl transferase and application thereof
WO2023030065A1 (en) * 2021-08-30 2023-03-09 弈柯莱生物科技(上海)股份有限公司 Glycosyltransferase and application thereof
CN116555210A (en) * 2022-01-30 2023-08-08 弈柯莱生物科技(上海)股份有限公司 Glycosyltransferases and their use in the preparation of rebaudioside E

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106754595A (en) * 2016-12-13 2017-05-31 南京工业大学 Recombinant bacterium and application thereof in catalyzing rebaudioside A to generate rebaudioside D
CN106834389A (en) * 2016-12-13 2017-06-13 南京工业大学 Method for preparing rebaudioside M2 by catalyzing rebaudioside A through recombinant bacteria
CN109750072A (en) * 2019-01-31 2019-05-14 南京工业大学 Method for preparing rebaudioside E by enzyme method
CN110592043A (en) * 2019-11-01 2019-12-20 广西师范大学 UDP-glucosyltransferase mutant and application thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106754595A (en) * 2016-12-13 2017-05-31 南京工业大学 Recombinant bacterium and application thereof in catalyzing rebaudioside A to generate rebaudioside D
CN106834389A (en) * 2016-12-13 2017-06-13 南京工业大学 Method for preparing rebaudioside M2 by catalyzing rebaudioside A through recombinant bacteria
CN109750072A (en) * 2019-01-31 2019-05-14 南京工业大学 Method for preparing rebaudioside E by enzyme method
CN110592043A (en) * 2019-11-01 2019-12-20 广西师范大学 UDP-glucosyltransferase mutant and application thereof

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115404226B (en) * 2021-05-27 2024-02-23 南京工业大学 Sucrose synthase and application thereof in catalyzing glycosylation reaction
CN115404226A (en) * 2021-05-27 2022-11-29 南京工业大学 Sucrose synthase and application thereof in catalytic glycosylation reaction
CN115418358A (en) * 2021-06-01 2022-12-02 弈柯莱生物科技(上海)股份有限公司 Glycosyl transferase and application thereof
CN115418358B (en) * 2021-06-01 2024-01-30 弈柯莱生物科技(集团)股份有限公司 Glycosyltransferase and application thereof
WO2022257983A1 (en) * 2021-06-08 2022-12-15 弈柯莱生物科技(上海)股份有限公司 β-1,2-GLYCOSYLTRANSFERASE, AND APPLICATION THEREOF
CN115478060B (en) * 2021-06-16 2023-11-28 弈柯莱生物科技(集团)股份有限公司 Glycosyltransferase and application thereof
CN115478060A (en) * 2021-06-16 2022-12-16 弈柯莱生物科技(上海)股份有限公司 Glycosyl transferase and application thereof
WO2023024828A1 (en) * 2021-08-23 2023-03-02 兴化格林生物制品有限公司 Glycosyltransferase mutant and method for catalytic synthesis of rebaudioside m by means of using same
CN113462670A (en) * 2021-08-23 2021-10-01 南京工业大学 Glycosyltransferase mutant and method for catalytically synthesizing rebaudioside M by using same
WO2023030065A1 (en) * 2021-08-30 2023-03-09 弈柯莱生物科技(上海)股份有限公司 Glycosyltransferase and application thereof
CN116555210A (en) * 2022-01-30 2023-08-08 弈柯莱生物科技(上海)股份有限公司 Glycosyltransferases and their use in the preparation of rebaudioside E
CN114875007B (en) * 2022-06-29 2023-09-05 上海交通大学 Glycosyltransferase mutant with improved heat and organic solvent stability
CN114875007A (en) * 2022-06-29 2022-08-09 上海交通大学 Glycosyltransferase mutant with improved heat and organic solvent stability

Also Published As

Publication number Publication date
CN112375750B (en) 2022-06-03

Similar Documents

Publication Publication Date Title
CN112375750B (en) Glycosyltransferase mutant and method for catalytically synthesizing rebaudioside A by using same
CN111712570B (en) Engineering strain for producing psicose and derivatives thereof, construction method and application thereof
CN109750072B (en) Method for preparing rebaudioside E by enzyme method
EP4365285A1 (en) Glycosyltransferase mutant and method for catalytic synthesis of rebaudioside m by means of using same
CN107723307A (en) A kind of method and its application for efficiently preparing the epimerase of D psicoses 3
CN109988799A (en) A kind of glycerol -2- alpha-glucosyl enzyme is preparing the application in 2- α-glycosylglycerol
JP7241368B2 (en) Ulva polysaccharide lyase and its coding gene and application
CN112708567B (en) Fructosyltransferase and high-yield strain thereof
CN105734092B (en) A kind of method that enzyme process prepares D-Tag
CN115960875A (en) Alginate lyase mutant enzyme with improved thermal stability
JP2003523203A (en) Bacterial isolate of the genus Klebsiella and isomaltulose synthase gene isolated therefrom
CN113862319A (en) Application of ginseng glycosyltransferase in synthesis of stevioside
KR20090125004A (en) Aldohexose epimerase and method for the enzymatic preparation of an aldohexose epimer using the same
CN110904088B (en) High-temperature-resistant D-psicose3-epimerase, mutant and application thereof
CN118103513A (en) Engineering bacterium for efficiently expressing D-psicose 3-epimerase and application
CN115841846A (en) Calculation method of amino acid candidate mutation sites of recognition enzyme
CN106119235B (en) A kind of DPE and its application from bulkholderia cepasea
CN115725484A (en) Enzyme mutation expression engineering bacterium for synthesizing D-psicose and application thereof
CN113373135B (en) Mutant of D-psicose 3-epimerase and application thereof
CN116286712B (en) Rhamnosyl transferase mutant, coding gene, preparation method and application
CN113583991B (en) Amylosucrase SaAS and encoding gene and application thereof
CN117737024B (en) Glycosyltransferase mutant and method for preparing acute ischemic cerebral apoplexy candidate drug SHPL-49 by using same
CN115261366B (en) High-temperature-resistant cellobiose epimerase mutant, engineering bacterium and application thereof
CN115261367B (en) Cellobiose epimerase mutant and application thereof
CN110452899B (en) Glucose isomerase, mutant and application of mutant in preparation of D-fructose

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant